The miR186-BAG2-ERK1/2 axis is involved in gastric cancer progression, which may provide a molecular basis for understanding of the pathophysiological function of BAG2, in addition to support the fact that these molecules could comprise a potential target for gastric cancer. Here, BAG2 is linked to gastric cancer.